DD250533A5 - Verfahren zur herstellung eines dihydropyridinderivates - Google Patents

Verfahren zur herstellung eines dihydropyridinderivates Download PDF

Info

Publication number
DD250533A5
DD250533A5 DD86286947A DD28694786A DD250533A5 DD 250533 A5 DD250533 A5 DD 250533A5 DD 86286947 A DD86286947 A DD 86286947A DD 28694786 A DD28694786 A DD 28694786A DD 250533 A5 DD250533 A5 DD 250533A5
Authority
DD
German Democratic Republic
Prior art keywords
carbon atoms
hydroxy
formula
group
dicarboxylate
Prior art date
Application number
DD86286947A
Other languages
German (de)
English (en)
Inventor
Rodney B Hargreaves
Bernard J Mcloughlin
Stuart D Mills
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD250533A5 publication Critical patent/DD250533A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD86286947A 1985-02-11 1986-02-10 Verfahren zur herstellung eines dihydropyridinderivates DD250533A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503425A GB8503425D0 (en) 1985-02-11 1985-02-11 Alkanolamine derivatives

Publications (1)

Publication Number Publication Date
DD250533A5 true DD250533A5 (de) 1987-10-14

Family

ID=10574270

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86286947A DD250533A5 (de) 1985-02-11 1986-02-10 Verfahren zur herstellung eines dihydropyridinderivates

Country Status (21)

Country Link
US (1) US4873254A (ja)
EP (1) EP0194751B1 (ja)
JP (1) JPH0819100B2 (ja)
KR (1) KR860006443A (ja)
AU (1) AU5339486A (ja)
CS (1) CS273172B2 (ja)
DD (1) DD250533A5 (ja)
DE (1) DE3684803D1 (ja)
DK (1) DK66186A (ja)
ES (2) ES8802139A1 (ja)
FI (1) FI860621A (ja)
GB (2) GB8503425D0 (ja)
GR (1) GR860369B (ja)
HU (1) HU196179B (ja)
NO (1) NO860465L (ja)
NZ (1) NZ215083A (ja)
PH (1) PH22683A (ja)
PL (2) PL153857B1 (ja)
PT (1) PT82008B (ja)
SU (1) SU1590041A3 (ja)
ZA (1) ZA86967B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6112662A (ja) * 1984-06-28 1986-01-21 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体及びその製法
US4782160A (en) * 1986-12-08 1988-11-01 Yamanouchi Pharmaceutical Co., Ltd. 1,4-dihydropyridine derivatives
GB9102031D0 (en) * 1991-01-30 1991-03-13 Fujisawa Pharmaceutical Co Dihydropyridine compounds,and process for their preparation
AU8430098A (en) * 1998-07-23 2000-02-14 Ing-Jun Chen Guaiacoxypropanolamines with alpha/beta-adrenergic blocking activity
US8076516B2 (en) 2007-11-01 2011-12-13 Acucela, Inc. Amine derivative compounds for treating ophthalmic diseases and disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
US4500527A (en) * 1983-06-22 1985-02-19 Usv Pharmaceutical Corporation Antihypertensive 4[(3-alkylamino-2-hydroxypropyl)-oxyiminomethyl phenyl]-1,4-dihydropyridines
JPS6112662A (ja) * 1984-06-28 1986-01-21 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体及びその製法

Also Published As

Publication number Publication date
DK66186A (da) 1986-08-12
AU5339486A (en) 1986-08-14
ZA86967B (en) 1986-11-26
US4873254A (en) 1989-10-10
HUT40415A (en) 1986-12-28
SU1590041A3 (ru) 1990-08-30
GB8602704D0 (en) 1986-03-12
PL153857B1 (en) 1991-06-28
GB8503425D0 (en) 1985-03-13
PL265252A1 (en) 1988-06-09
GR860369B (en) 1986-06-02
PH22683A (en) 1988-11-14
KR860006443A (ko) 1986-09-11
JPH0819100B2 (ja) 1996-02-28
EP0194751A1 (en) 1986-09-17
PL149828B1 (en) 1990-03-31
FI860621A (fi) 1986-08-12
EP0194751B1 (en) 1992-04-15
JPS61233669A (ja) 1986-10-17
CS91186A2 (en) 1990-07-12
NO860465L (no) 1986-08-12
ES551844A0 (es) 1988-04-01
PT82008B (pt) 1988-07-01
ES8802139A1 (es) 1988-04-01
HU196179B (en) 1988-10-28
ES557630A0 (es) 1988-07-01
PT82008A (en) 1986-03-01
DE3684803D1 (de) 1992-05-21
FI860621A0 (fi) 1986-02-11
ES8802496A1 (es) 1988-07-01
DK66186D0 (da) 1986-02-11
CS273172B2 (en) 1991-03-12
NZ215083A (en) 1989-10-27
PL257902A1 (en) 1988-03-03

Similar Documents

Publication Publication Date Title
DE3787346T2 (de) Dihydropyridin-Derivate, ihre Herstellung und ihre Verwendung.
CH664757A5 (de) Pharmazeutisch nuetzliche dihydropyridinylcarbonsaeureamide und ester.
CH642353A5 (de) 2-methyl-dihydropyridin-verbindung, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel.
DE2651083A1 (de) Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
DE3042769A1 (de) C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
DE69720021T2 (de) 1,4-disubstituierte piperazine
EP0008645B1 (de) Alkoxyphenylpyrrolidone, Verfahren zu ihrer Herstellung und Arzneimittel auf Basis dieser Verbindungen
WO1986004581A1 (en) Dihydropyridine alkanolamines
DE69102477T2 (de) 3-Aminochroman-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DD250533A5 (de) Verfahren zur herstellung eines dihydropyridinderivates
DE60013225T2 (de) 4-Hydroxy-4-Phenylpiperidin-Derivate mit opioid-agonistischer Aktivität und di ese enthaltende Pharmazeutika
DD219770A5 (de) Verfahren zur herstellung von piperidindion-derivaten
DE2650013C3 (de) 1.4-Dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsäureisopropyl-(2-propoxy-äthyl)-ester, Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE4117750A1 (de) Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
EP0018360A1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung.
DE68912252T2 (de) Imidazolantiarrythmische Mittel.
EP0123700A1 (de) Substituierte Picolinsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
DE2412520A1 (de) Tricyclische verbindungen
EP0072961A1 (de) 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69007045T2 (de) Piperidinderivate, Verfahren zur Herstellung sowie diese enthaltende pharmazeutische Präparate.
EP0657432B1 (de) Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität
DE2437883C3 (de) N-Substltuierte Glycinester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0194047A1 (en) Dihydropyridine alkanol amines, process for their preparation and pharmaceutical compositions containing them
EP0322396A1 (de) Neue Derivate von Benzimidazol, ihre Herstellung und Verwendung
DE3744549A1 (de) 12h-12-(carbamoyl)- beziehungsweise 12h-12-aminoalkanoyl)-dibenzo(d,g)(1,3,6)dioxazocinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel